Evidence map›Paper›PMID 42095306›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Developing Micro/Nanostructured Fluidic Mixing Technology for Biomedical Applications.

Junkai Wang, Hanxu Chen, Yile Fang, Yuanjin Zhao

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Junkai WangDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, China.ORCID https://orcid.org/0009-0002-5166-9057
Hanxu ChenDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, China.
Yile FangDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, China.
Yuanjin ZhaoDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0001-9242-4000

Funding

Clinical Trials from Nanjing Drum Tower Hospital 2022-LCYJ-ZD-01Joint Fund of Henan Province Science and Technology R&D Program 225200810021Key Research & Development Program of Jiangsu Province BE2023653National Key Research and Development Program of China 2022YFA1105300National Natural Science Foundation of China T2225003Yangtze River Pharmaceutical Group
6 · The paper itself

Abstract

Fluid mixing technologies are indispensable in the fields of biomedicine and biotechnology, where precise control over mixing processes is essential for optimal performance. Traditional mixing systems, such as stirred tanks, jet-flow mixers, and mechanical drives, often suffer from limitations in terms of precision, scalability, and energy efficiency, especially when adapted to complex biomedical applications. Recent developments in micro/nanostructured fluid mixing technologies offer promising solutions to these challenges by enabling efficient, controllable, and energy-saving mixing at the microscale. These technologies leverage intricate micro/nanostructures that can enhance diffusion, induce vortices, and generate chaotic convection, thus overcoming the constraints faced by conventional methods. In this paper, we systematically classify these micro/nanostructures based on the fluid mixing phenomena they exploit and review their applications across a range of biomedical fields, including biomaterials fabrication, drug development, cell culture, organs-on-chips, biosensing, and diagnostics. We also examine how these technologies contribute to advancements in precision medicine, personalized treatment, and high-throughput testing. Finally, we discuss the future challenges, opportunities, and interdisciplinary collaboration needed to further advance the clinical and industrial adoption of micro/nanostructured fluid mixing technologies.

Indexed as

BiotechnologyMicrofluidicsNanostructuresNanotechnologyAnimalsBiocompatible MaterialsBiosensing TechniquesHumansBiocompatible Materialsbiomedical applicationsfluidic mixinghydrodynamicsmicrofluidicsmicro/nanostructured

Identifiers

PMID42095306
PMCPMC13271631

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.